Dev

Diagnostic tools for neurodegenerative disease biomarkers based on robust optically signaling capture phases Investments > €500k Sweden Alzheimer’s disease & other dementias 2016    

Towards an understanding of aging and neurodegenerative disease using novel stem cell, reprogramming and genome editing technologies Investments > €500k Sweden Alzheimer’s disease & other dementias 2016    

Pericytes in mechanisms linking type 2 diabetes to increased risk of dementia. Investments > €500k Sweden Alzheimer’s disease & other dementias 2016    

Studies of molecular mechanisms in Alzheimer’s disease using imaging mass spectrometry Investments > €500k Sweden Alzheimer’s disease & other dementias 2016    

Phase I program with IRL790 for treatment of dyskinesias and psychosis in Parkinson´s disease Investments > €500k Sweden Parkinson’s disease & PD-related disorders 2016    

Treatment of late stages of Parkinson´s disease with a highly concentrated DOPA solution administered subcutaneously or intravenously – a national, multicenter, academia-based trial Investments > €500k Sweden Parkinson’s disease & PD-related disorders 2016    

´Multimodal motor symptoms quantification platform for individualized Parkinson´s disease treatments´ MuSyQ Investments > €500k Sweden Parkinson’s disease & PD-related disorders 2016    

The Two Horizons of Research. Cultural Analysis of How Patients and Scientists Face Each Other in Clinical Trials within the Research on Parkinson´s Disease Investments > €500k Sweden Parkinson’s disease & PD-related disorders 2016    

Patient-specific treatment for Parkinson’s disease using reprogrammed skin cells Investments > €500k Sweden Parkinson’s disease & PD-related disorders 2016    

Stem cell therapy for stroke and other neurodegenerative diseases Investments > €500k Sweden Parkinson’s disease & PD-related disorders 2016